Results 21 to 30 of about 535,496 (194)

Preemptive Therapy in Cryptococcosis Adjusted for Outcomes

open access: yesJournal of Fungi, 2023
Cryptococcosis is one of the most serious opportunistic diseases in patients living with HIV. For this reason, early diagnosis and appropriate treatment are important. Objectives.
Fernando Messina   +5 more
doaj   +1 more source

Pulmonary cryptococcosis coexisting with central type lung cancer in an immuocompetent patient: a case report and literature review

open access: yesBMC Pulmonary Medicine, 2020
Background Pulmonary Cryptococcosis is a common fungal infection mainly caused by Cryptococcus neoformans/C.gattii species in immunocompromised patients. Cases of pulmonary cryptococcosis in patients with normal immune function are increasingly common in
Kelin Yao   +7 more
doaj   +1 more source

Incidental diagnosis of pulmonary cryptococcosis by rebiopsy for epidermal growth factor receptor T790M mutation: A case report

open access: yesThoracic Cancer, 2023
Cryptococcosis is an invasive fungal infection that can occur in cancer patients. A case of pulmonary cryptococcosis in a patient treated with erlotinib + ramucirumab for epidermal growth factor receptor (EGFR) L858R point mutation‐positive non‐small ...
Hiroshi Kobe   +2 more
doaj   +1 more source

Primary pulmonary cryptococcosis [PDF]

open access: yesBMJ Case Reports, 2014
Here, we report a case of primary cryptococcal pneumonia in a 25-year-old woman who presented with several weeks’ history of cough, dyspnoea and night sweating. These symptoms started in the third trimester of her pregnancy. She was being treated for infertility and got pregnant with in vitro fertilisation.
Mehrnaz, Asadi Gharabaghi   +1 more
openaire   +2 more sources

Experimental models of cryptococcosis. [PDF]

open access: yes, 2011
Cryptococcosis is a life-threatening fungal disease that infects around one million people each year. Establishment and progression of disease involves a complex interplay between the fungus and a diverse range of host cell types.
May, Robin C   +9 more
core   +1 more source

Concurrent Subcutaneous Candidal Abscesses and Pulmonary Cryptococcosis in a Patient with Diabetes Mellitus and a History of Corticosteroid Therapy [PDF]

open access: yes, 2014
A 50-year-old man with a history of long-term corticosteroid treatment following adrenalectomy for Cushing's syndrome and uncontrolled diabetes mellitus was admitted for an examination of an abnormal thoracic shadow.
Miyazaki, Taiga   +35 more
core   +1 more source

Cryptococcus, Pathological observations of five autopsy cases and one biopsy case [PDF]

open access: yes, 1959
Pathologic, anatomical, and histological findings of 5 autopsy cases and one biopsy case of cryptococcosis have been described. Macroscopically the foci of the lung are grayish white or yellowish white in color and range in size from the small acinous ...
Ogawa, Katsuo   +5 more
core   +1 more source

Pulmonary cryptococcosis closely mimicking lung cancer in a membranous nephropathy patient taking calcineurin inhibitor

open access: yesIDCases, 2023
In patients with membranous nephropathy (MN), malignancy may be either the underlying disease or results of immunosuppressive therapy which may also lead to opportunistic infections including the pulmonary cryptococcosis.
ZhiPeng Zhao   +5 more
doaj   +1 more source

Pulmonary Cryptococcosis Infection in Non-HIV Patients in a Tertiary Care Center in Taiwan. [PDF]

open access: yesPulm Med
BACKGROUND: Pulmonary cryptococcosis is an important opportunistic fungal infection in immunocompromised individuals, including those with an infection of the human immunodeficiency virus (HIV) but it can be increasingly seen in non\u2010HIV patients ...
Tu KC   +5 more
europepmc   +2 more sources

Flucytosine and cryptococcosis: time to urgently address the worldwide accessibility of a 50-year-old antifungal. [PDF]

open access: yes, 2013
Current, widely accepted guidelines for the management of HIV-associated cryptococcal meningoencephalitis (CM) recommend amphotericin B combined with flucytosine (5-FC) for ≥2 weeks as the initial induction treatment of choice.
A. Loyse   +10 more
core   +1 more source

Home - About - Disclaimer - Privacy